J 2020

Inaccuracy of Self-Completed COPD Assessment Test by Older Patients Leads to Underestimation of Disease Severity

KOBLIZEK, Vladimir, Vladimir ZINDR, Ondrej ZINDR, Stanislav HOLUB, Anna HRAZDIROVÁ et. al.

Basic information

Original name

Inaccuracy of Self-Completed COPD Assessment Test by Older Patients Leads to Underestimation of Disease Severity

Authors

KOBLIZEK, Vladimir (203 Czech Republic, guarantor), Vladimir ZINDR (203 Czech Republic), Ondrej ZINDR (203 Czech Republic), Stanislav HOLUB (203 Czech Republic), Anna HRAZDIROVÁ (203 Czech Republic, belonging to the institution), Jana KOCIANOVA (203 Czech Republic), Michal SVOBODA (203 Czech Republic, belonging to the institution) and Petr DULICEK (203 Czech Republic)

Edition

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, NEW YORK, ELSEVIER SCIENCE INC, 2020, 1525-8610

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30227 Geriatrics and gerontology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.669

RIV identification code

RIV/00216224:14110/20:00115253

Organization unit

Faculty of Medicine

UT WoS

000504685400027

Keywords in English

Self-Completed COPD Assessment Test; Disease Severity

Tags

International impact, Reviewed
Změněno: 12/5/2021 12:52, Mgr. Tereza Miškechová

Abstract

V originále

Chronic obstructive pulmonary disease (COPD), a life-threatening condition, represents a considerable public health and socioeconomic challenge.1 Symptoms of this long-lasting respiratory disease can significantly impair patients' daily physical activities, reduce quality of life, and lead to excessive health care overuse. Modified Medical Research Council dyspnea scale is a basic tool for determining symptoms of dyspnea in COPD patients. However, because COPD subjects suffer from complex symptomatology, COPD Assessment Test (CAT), a validated patient-completed questionnaire, is now globally recommended as the first choice assessment tool to classify COPD individuals according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease, Inc) Strategy in daily practice.